PMA device
FreeStyle Libre 14-day Flash Glucose Monitoring System
Abbott Diabetes Care, Inc. · Sensor, Glucose, Invasive, Non-Adjunctive, Factory-Calibrated, User-Initiated (PZE, Class III) · First FDA decision Jan 17, 2023, newest Jan 17, 2023Diabetes
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
41
Naming "FreeStyle Libre 14-day"
MAUDE reports
34,883
Brand "FreeStyle Libre 14-day", since 2015
PubMed studies
7
Mentioning "FreeStyle Libre 14-day"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing FreeStyle Libre 14-day Flash Glucose Monitoring System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- FreeStyle Libre 14-day Flash Glucose Monitoring SystemPMA supplement
P160030-S052 · Decided Jan 17, 2023 · 29 days after receipt · Normal 180 Day Track No User Fee
Device type: Sensor, glucose, invasive, non-adjunctive, factory-calibrated, user-initiated (PZE) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "FreeStyle Libre 14-day", any status and sponsor, newest update first.
- Glucose Pattern in Infertile Women Receiving Assisted Reproduction Using Continuous Glucose MonitoringActive, not recruiting
Shanghai 6th People's HospitalAcademic, hospital or other
NCT06863337 · 100 participants (planned) · Start Mar 26, 2025 · Primary completion Jun 30, 2026
Device: CGM · For: Infertility Female
Sites: Shanghai, China
IMDEA FoodAcademic, hospital or other
NCT07626658 · 471 participants (planned) · Start Oct 15, 2026 · Primary completion May 2028
Device: Continuous glucose monitoring using a wearable sensor (flash interstitial glucose monitor) · For: Prediabetes (Insulin Resistance, Impaired Glucose Tolerance); Artificial Intelligence Mobile Application
Sites: Madrid, Spain
- Inter-Arm Differences in Continuous Glucose Monitor Readings in Adults With DiabetesNot yet recruiting
University of the PacificAcademic, hospital or other
NCT07920341 · 60 participants (planned) · Start Nov 4, 2026 · Primary completion Nov 4, 2027
Device: FreeStyle Libre 3 Plus Continuous Glucose Monitor · For: Continuous Glucose Monitoring; Type 1 Diabetes; Type 2 Diabetes
Sites: Stockton, California
38 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "FreeStyle Libre 14-day", and for the whole product code for context.
This brand
34,883 reports: 21,826 malfunction, 13,037 injury, 12 death
Whole product code PZE
143,343 reports: 125,788 malfunction, 17,533 injury, 14 death
Newest reports for this brand
- FreeStyle Libre 14 DayInjury
2954323-2026-447826 · Received Oct 28, 2026 · Event dated Sep 28, 2026
Device type: Sensor, Glucose, Invasive, Non-Adjunctive, Factory-Calibrated, User-Initiated (PZE)
Device problem as coded: Unable to Obtain Readings; Device Displays Incorrect Message
Patient problem as coded: Bruise/Contusion; Headache; Hypoglycemia; Loss of consciousness
- FreeStyle Libre 14 DayMalfunction
2954323-2026-445926 · Received Oct 26, 2026 · Event dated Oct 1, 2026
Device type: Sensor, Glucose, Invasive, Non-Adjunctive, Factory-Calibrated, User-Initiated (PZE)
Device problem as coded: Incorrect, Inadequate or Imprecise Result or Readings
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- FreeStyle Libre 14 DayMalfunction
2954323-2026-446250 · Received Oct 26, 2026 · Event dated Oct 12, 2026
Device type: Sensor, Glucose, Invasive, Non-Adjunctive, Factory-Calibrated, User-Initiated (PZE)
Device problem as coded: Detachment of Device or Device Component
Patient problem as coded: Device Embedded In Tissue or Plaque
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- FreeStyle Libre Reader, REF: 71525-01, 71701-01, 71739-01 a component of the FreeStyle Libre Flash Glucose Monitoring SystemOpen, Classified
Z-1273-2023 · Started Feb 13, 2023 · Posted by FDA Apr 6, 2023
Reason given: Lithium-ion batteries in glucose monitoring system readers may swell, overheat, or pose fire hazard. Only use the charging cable/power adapter included with readers. Do not use reader if it is damaged, cracked, swelling, too hot to hold, it will no longer hold charge, or it fails Reader Test. Do not use other...
Cause as FDA categorized it: Device Design · Device type: Sensor, Glucose, Invasive, Non-Adjunctive, Factory-Calibrated, User-Initiated (PZE)
Published research
The most relevant PubMed records for "FreeStyle Libre 14-day"[tiab]. The summary above synthesizes these.
- Flash Continuous Glucose Monitoring (FreeStyle Libre 14-Day System) for Self-Management of Diabetes Mellitus.
Choi HYJ · Am Fam Physician · 2021
- Hip sensor location for flash interstitial glucose monitoring system provides adequate clinical accuracy in non-diabetic hypoglycemic dogs.
Evans JB, Lidbury JA, Jeffery N, et al. · Am J Vet Res · 2023
- Comparison of an Intermittently Scanned (Flash) Continuous Glucose Monitoring System to Standard Self-Monitoring of Capillary Blood Glucose in Gestational Diabetes Mellitus.
Hussain FN, Raymond S, Feldman KM, et al. · Am J Perinatol · 2023
- Lower Glycated Hemoglobin with Real-Time Continuous Glucose Monitoring Than with Intermittently Scanned Continuous Glucose Monitoring After 1 Year: The CORRIDA LIFE Study.
Radovnická L, Hásková A, Do QD, et al. · Diabetes Technol Ther · 2022Clinical Trial, Research Support, Non-U.S. Gov't
- Comparison of two glucose-monitoring systems for use in horses.
Malik CE, Wong DM, Dembek KA, et al. · Am J Vet Res · 2022
- Analysis of "Accuracy of a 14-Day Factory Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes".
Kompala T, Neinstein AB · J Diabetes Sci Technol · 2022Comment
- Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults.
Kudva YC, Ahmann AJ, Bergenstal RM, et al. · J Endocr Soc · 2018Review
Other devices of this type
Also filed under product code PZE.
- FreeStyle Libre 14 day Flash Glucose Monitoring SystemAbbott Diabetes Care, Inc. · PMA 2024
- Freestyle Libre Flash Glucose Monitoring SystemAbbott Diabetes Care, Inc. · PMA 2019
- Freestyle Libre ProAbbott Diabetes Care, Inc. · PMA 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.